Trial intelligence / Profile preview

Melatonin versus placebo in acute ischemic stroke

IRCT20120215009014N378Phase 3Completed

Sponsor
Hamadan University of Medical Sciences
Start
May 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in ischemic stroke comparing Melatonin arm with Placebo arm (2 arms). Started May 2021; status: completed.

02

Drugs

melatonin
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on IRCT20120215009014N378.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120215009014N378.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call